Cabergoline Treatment Report
Most Popular Brands: Cabaser
What is Cabergoline?
Cabergoline is an ergot-derived dopamine agonist used in the treatment of Parkinson's disease. Due to elevated levels of heart problems, ergot-derived agonists are being phased out of clinical use.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat Parkinson's | 4 |
|
|
3 | |||
| Treat Parkinson's disease | 1 | 0 |
Mouse over the table for more information
Side Effects
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
4 | 100% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 3 patient evaluations
-
- juliaR
- Sex: F
- Mouth/throat: mild
- Arms: mild
- Chest: mild
- Legs: moderate
- See profile
-
-
- juliaR
- 4 mg daily
- since Aug 02, 2009
-
Efficacy
Major
for Treat Parkinson's
-
Side Effects
Mild
- Advice/Tips Be aware of the valvular problems and fibrosis. Keep getting checked through an echocardiogram See full evaluation
See all 3 patient evaluations
Report created on November 22, 2009.